1ndia on Saturday was at the forefront with
The European Union and the United States made a joint proposal through the World Trade Organization to remove specific barriers to trade in clean energy technologies like wind turbines and solar panels as part of the long- running Doha round of talks.
2. GSK drops its patent claim on 2 AIDS Drugs.
In a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy GlaxosmithKline (GSK) has pulled out the patent applications of two anti-AIDS medicines in
While GSK has formally withdrawn the application of Abacavir, it is learnt that the
Abacavir is a second-line anti-retroviral (ARV) drug used to treat patients who have developed resistance to first-line medications. Trizivir is a combine of three ARV drugs used for first and second-line treatments. Indian firms like Cipla, Ranbaxy and Hetero, among others, already market one or both these drugs in
“The applicant (GSK) of this instant application has withdrawn the application under reference (Abacavir). Accordingly, there will be no further proceedings towards the representation, “the examiner of the Patent and Design office in Kolkata said in a order. (Economic times)
The two developing countries, who play a major role in the talks, said that a U.S.-EU proposal to free up trade in environmental goods was little more than a disguised attempt to boost sales of goods of rich nations.
They also said a negotiating text on “rules” — anti-dumping, subsidies and fisheries subsidies — was a step backwards that excessively accommodated
Brazil India like teenage drivers in WTO talks, says U.S. Brazil and India have pushed their way to the “big table” in world trade talks and are struggling with the responsibility that it entails, like teen-agers who have just gotten their driver’s license, U.S. Trade Representative Susan Schwab said on Tuesday.
After insisting that developing countries have more say in the outcome of the negotiations, “these countries now find themselves at the big table, or in the small room or whatever description you want,” Schwab told the President’s Export Council in a short briefing on the 6-year-old
4. Sun settles Patent row with Novartis
Sun Pharmaceutical Industries has reached an out-of-court settlement with Novartis in the United States with regard to a patent dispute over the Swiss drug major’s Alzheimer’s drugExelon.
“Under the terms of the settlement, Sun Pharma will not market generic Exelon in the
6. Nasscom wants Fast Track Courts to try Cyber Crimes.-Extend Sunset Clause to IT
The National Association of Software and Service Companies (Nasscom) has expressed ‘serious concern’ over the spurt in rupee value against the U.S. dollar. IT companies are going to be hit hard, if the trend continues at this pace for five more years,” according to the President of Nasscom, Kiran Karnik.
The association wanted the Government to essentially involve Data Security Council of India (DSCI), the self-regulatory organization (SRO) on information security, in policy decisions and confer the status of ‘consultative body’ on it.
The DSCI was in dialogue with the Parliamentary Standing Committee on amendments to the Information Technology Act, 2000, to further tighten the rules on contractual forms, digitization of signatures and intensity of punishment for cyber crimes.
Nasscom’s security initiatives suggested a ‘4E framework’ — Engagement, Education, Enactment and Enforcement.
He also wanted the Government to set up fast track courts exclusively to try cyber crimes.(Economic Times)
The National Association of Software and Service Companies (Nasscom) and
7. India-Telecom 2007-‘Digital Divide to Digital Opportunities’
The Department of Telecommunications, Ministry of Communications &Information Technology, Government of India in association with the Federation of Indian Chambers of Commerce &Industry will host the 2nd International Exhibition &Conference between the 12-15th December 2007, Pragati Maidan,